Literature DB >> 27722838

The epidemiology of mortality after fracture in England: variation by age, sex, time, geographic location, and ethnicity.

C Klop1, T P van Staa1,2, C Cooper3,4,5, N C Harvey6,7, F de Vries1,6,8,9.   

Abstract

One-year mortality following a fracture was greater for men compared to women, varied markedly between regions in England with the lowest rates in the London region, and was higher among black women compared to white women. The excess in mortality did not change during the study period.
INTRODUCTION: Fractures are associated with increased mortality. With the shift towards an increasingly elderly demography, and so increasing numbers of fractures, the impact of such events on mortality is of key public health importance. Therefore, we aimed to present up-to-date mortality rates following fracture in England.
METHODS: This was a population-based study within the Clinical Practice Research Datalink, linked to death certificates (1 January 2001 to 31 December 2011). Subjects were followed from their first fracture (hip, wrist, humerus, clinical spine, ribs, or pelvis) until death for up to 1 year. Rate ratios (RRs) were estimated for 1-year mortality, stratified by sex, 5-year age categories, ethnicity, and geographical region. Excess mortality was presented as standardized mortality ratios (SMRs).
RESULTS: One-year mortality following fracture increased with age and was higher for men than women. Black women (RR 1.77; 95 % CI 1.00-3.12) and women of "other" ethnicity (RR 1.59, 95 % CI 1.16-2.16) were at higher risk of death when compared to white women. Mortality was higher among women in almost all regions when compared to the London region, with the highest risk in the East Midlands (37 % higher). The 1-year mortality risk was more than 3-fold higher after fracture as compared to the general population (adjusted SMR: 3.15, 95 % CI 3.09-3.26) and did not change during the study period. Major causes of death were neoplasms, respiratory diseases, and circulatory diseases.
CONCLUSION: This study provides up-to-date mortality outcomes following fracture in England and will aid allocation of healthcare provision to those at greatest need.

Entities:  

Keywords:  Comorbidity; Epidemiology; Mortality; Osteoporosis

Mesh:

Year:  2016        PMID: 27722838      PMCID: PMC5214576          DOI: 10.1007/s00198-016-3787-0

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  28 in total

1.  Admission rates and in-hospital mortality for hip fractures in England 1998 to 2009: time trends study.

Authors:  Tai-Yin Wu; Min-Hua Jen; Alex Bottle; Chen-Kun Liaw; Paul Aylin; Azeem Majeed
Journal:  J Public Health (Oxf)       Date:  2010-10-05       Impact factor: 2.341

2.  Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey.

Authors:  James D Lewis; Colleen Brensinger
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-07       Impact factor: 2.890

3.  Meta-analysis: excess mortality after hip fracture among older women and men.

Authors:  Patrick Haentjens; Jay Magaziner; Cathleen S Colón-Emeric; Dirk Vanderschueren; Koen Milisen; Brigitte Velkeniers; Steven Boonen
Journal:  Ann Intern Med       Date:  2010-03-16       Impact factor: 25.391

4.  Race and sex differences in mortality following fracture of the hip.

Authors:  S J Jacobsen; J Goldberg; T P Miles; J A Brody; W Stiers; A A Rimm
Journal:  Am J Public Health       Date:  1992-08       Impact factor: 9.308

5.  Patterns of rehabilitation utilization after hip fracture in acute hospitals and skilled nursing facilities.

Authors:  N D Harada; A Chun; V Chiu; A Pakalniskis
Journal:  Med Care       Date:  2000-11       Impact factor: 2.983

6.  Treatment and survival among elderly Americans with hip fractures: a population-based study.

Authors:  G L Lu-Yao; J A Baron; J A Barrett; E S Fisher
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

7.  The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results.

Authors:  T P Van Staa; L Abenhaim; C Cooper; B Zhang; H G Leufkens
Journal:  Pharmacoepidemiol Drug Saf       Date:  2000-09       Impact factor: 2.890

8.  Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women.

Authors:  Dana Bliuc; Nguyen D Nguyen; Vivienne E Milch; Tuan V Nguyen; John A Eisman; Jacqueline R Center
Journal:  JAMA       Date:  2009-02-04       Impact factor: 56.272

Review 9.  Osteoporosis in the European Union: a compendium of country-specific reports.

Authors:  A Svedbom; E Hernlund; M Ivergård; J Compston; C Cooper; J Stenmark; E V McCloskey; B Jönsson; J A Kanis
Journal:  Arch Osteoporos       Date:  2013-10-11       Impact factor: 2.617

10.  Demographic factors in hip fracture incidence and mortality rates in California, 2000-2011.

Authors:  Kristynn J Sullivan; Lisa E Husak; Maria Altebarmakian; W Timothy Brox
Journal:  J Orthop Surg Res       Date:  2016-01-08       Impact factor: 2.359

View more
  14 in total

Review 1.  BMP gene delivery for skeletal tissue regeneration.

Authors:  Maxim Bez; Gadi Pelled; Dan Gazit
Journal:  Bone       Date:  2020-05-21       Impact factor: 4.398

Review 2.  Bibliometric analysis of global research trends on male osteoporosis: a neglected field deserves more attention.

Authors:  Haiyang Wu; Zaijie Sun; Linjian Tong; Yulin Wang; Hua Yan; Zhiming Sun
Journal:  Arch Osteoporos       Date:  2021-10-11       Impact factor: 2.617

3.  State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions.

Authors:  Kaleen M Lavin; Paul M Coen; Liliana C Baptista; Margaret B Bell; Devin Drummer; Sara A Harper; Manoel E Lixandrão; Jeremy S McAdam; Samia M O'Bryan; Sofhia Ramos; Lisa M Roberts; Rick B Vega; Bret H Goodpaster; Marcas M Bamman; Thomas W Buford
Journal:  Compr Physiol       Date:  2022-03-09       Impact factor: 8.915

Review 4.  Cardiovascular Safety and Effectiveness of Bisphosphonates: From Intervention Trials to Real-Life Data.

Authors:  Chiara Delli Poggi; Maria Fusaro; Maria Cristina Mereu; Maria Luisa Brandi; Luisella Cianferotti
Journal:  Nutrients       Date:  2022-06-07       Impact factor: 6.706

5.  The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study.

Authors:  Mikk Jürisson; Mait Raag; Riina Kallikorm; Margus Lember; Anneli Uusküla
Journal:  BMC Musculoskelet Disord       Date:  2017-06-05       Impact factor: 2.362

6.  Anticholinergic burden and fractures: a protocol for a methodological systematic review and meta-analysis.

Authors:  Jonas Reinold; Wiebke Schäfer; Lara Christianson; Francesco Barone-Adesi; Oliver Riedel; Federica Edith Pisa
Journal:  BMJ Open       Date:  2019-08-21       Impact factor: 2.692

7.  The incidence of hip fracture and mortality rate after hip fracture in Korea: A nationwide population-based cohort study.

Authors:  Sangmo Hong; Kyungdo Han
Journal:  Osteoporos Sarcopenia       Date:  2019-06-28

8.  Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project.

Authors:  Björn Runesson; Marco Trevisan; Ken Iseri; Abdul Rashid Qureshi; Bengt Lindholm; Peter Barany; Carl Gustaf Elinder; Juan Jesus Carrero
Journal:  Nephrol Dial Transplant       Date:  2020-11-01       Impact factor: 5.992

9.  Prior fragility fracture and risk of incident ischaemic cardiovascular events: results from UK Biobank.

Authors:  J Paccou; S D'Angelo; A Rhodes; E M Curtis; Z Raisi-Estabragh; M Edwards; K Walker-Bone; C Cooper; S E Petersen; N C Harvey
Journal:  Osteoporos Int       Date:  2018-02-26       Impact factor: 4.507

10.  Exercise and bone health across the lifespan.

Authors:  Lívia Santos; Kirsty Jayne Elliott-Sale; Craig Sale
Journal:  Biogerontology       Date:  2017-10-20       Impact factor: 4.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.